Video interviews of experts in the field reviewing research being presented at the 2023 AUA Annual Meeting.
EP. 1: 2023 AUA preview: Dr. Cookson on top research in prostate cancer
Michael S. Cookson, MD, MMHC, highlights 5 studies in prostate cancer being presented at the 2023 American Urological Association Annual Meeting.
EP. 2: 2023 AUA preview: Dr. Bernie on top research in sexual dysfunction
Helen L. Bernie, DO, MPH, highlights 4 studies in sexual dysfunction being presented at the 2023 American Urological Association Annual Meeting.
EP. 3: 2023 AUA preview: Dr. Laudano on top research in overactive bladder/incontinence
Melissa A. Laudano, MD, highlights 3 studies in overactive bladder/incontinence being presented at the 2023 American Urological Association Annual Meeting.
EP. 4: 2023 AUA preview: Dr. Li on top research in bladder cancer
Roger Li, MD, highlights 4 studies in bladder cancer being presented at the 2023 American Urological Association Annual Meeting.
NIAGARA: ctDNA analysis highlights durvalumab’s impact in MIBC
Nivolumab/ipilimumab continues to show improved survival, durable response in aRCC
Mixed results reported for nivolumab/ipilimumab in cisplatin-ineligible mUC
EV plus pembrolizumab doubles CR rate vs chemotherapy in la/mUC
